Heterologous production of myxobacterial α-pyrone antibiotics in Myxococcus xanthus

Metabolic Engineering

Volumn 44, Issue , 2017, Pages 160-170

  Sucipto, Hilda ^a   Pogorevc, Domen ^a   Luxenburger, Eva ^a   Wenzel, Silke C ^a   Müller, Rolf ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PRODUCTION PLATFORMS; RNA;

BROAD SPECTRUM; HETEROLOGOUS PRODUCTION; MICROBIAL PRODUCTION; MYXOCOCCUS XANTHUS; RNA POLYMERASE; STRUCTURE DESIGN; THERAPEUTIC AGENTS; YIELD IMPROVEMENT;

ANTIBIOTICS;

2 PYRONE DERIVATIVE; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CORALLOPYRONIN; CYTOCHROME P450; ENOYL COENZYME A HYDRATASE; KANAMYCIN; MYXOPYRONIN; POLYKETIDE SYNTHASE; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; LACTONE; PYRONE DERIVATIVE;

5' UNTRANSLATED REGION; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; COSMID VECTOR; EXPRESSION VECTOR; GENE CLUSTER; GENE EXPRESSION SYSTEM; HETEROLOGOUS EXPRESSION; HYBRID GENE; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MYXOCOCCUS FULVUS; MYXOCOCCUS XANTHUS; NONHUMAN; OVERLAPPING GENE; PENICILLIN RESISTANCE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION MAPPING; RESTRICTION SITE; BIOSYNTHESIS; GENETICS; METABOLIC ENGINEERING; METABOLISM;

ANTI-BACTERIAL AGENTS; LACTONES; METABOLIC ENGINEERING; MYXOCOCCUS XANTHUS; PYRONES;

EID: 85031777886     PISSN: 10967176     EISSN: 10967184     Source Type: Journal    
DOI: 10.1016/j.ymben.2017.10.004     Document Type: Article

References (36)

1. Belogurov, G.A., Vassylyeva, M.N., Sevostyanova, A., Appleman, J.R., Xiang, A.X., Lira, R., Webber, S.E., Klyuyev, S., Nudler, E., Artsimovitch, I., Vassylyev, D.G., Transcription inactivation through local refolding of the RNA polymerase structure. Nature, 2008, 10.1038/nature07510.
2. Bierman, M., Logan, R., Obrien, K., Seno, E.T., Rao, R.N., Schoner, B.E., Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp. Gene 116:1 (1992), 43–49.
3. Calderone, C.T., Isoprenoid-like alkylations in polyketide biosynthesis. Nat. Prod. Rep. 25:5 (2008), 845–853, 10.1039/b807243d.
4. Chang, A.C., Cohen, S.N., Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J. Bacteriol. 134:3 (1978), 1141–1156.
5. Ebright, R.H., Ebright, Y.W., Shen, J., Bacci, J., Hiebel, A.-.C., Solvibile, W., Self, C., Olson, G., 2016. Antibacterial Agents: Aryl Myxopyronin Derivatives.
6. Erol, Ö., Schäberle, T.F., Schmitz, A., Rachid, S., Gurgui, C., El Omari, M., Lohr, F., Kehraus, S., Piel, J., Müller, R., König, G.M., Biosynthesis of the myxobacterial antibiotic corallopyronin A. ChemBioChem 11:9 (2010), 1235–1265, 10.1002/cbic.201000085.
7. Finking, R., Marahiel, M.A., Biosynthesis of nonribosomal peptides. Annu. Rev. Microbiol. 58 (2004), 453–488, 10.1146/annurev.micro.58.030603.123615.
8. Goldstein, B.P., Resistance to rifampicin: a review. J. Antibiot. 67:9 (2014), 625–630, 10.1038/ja.2014.107.
9. Helfrich, E.J.N., Piel, J., Biosynthesis of polyketides by trans-AT polyketide synthases. Nat. Prod. Rep. 33:2 (2016), 231–316, 10.1039/c5np00125k.
10. Herrmann, J., Fayad, A.A., Müller, R., Natural products from myxobacteria: novel metabolites and bioactivities. Nat. Prod. Rep. 34:2 (2017), 135–160, 10.1039/C6NP00106H.
11. Irschik, H., Gerth, K., Höfle, G., Kohl, W., Reichenbach, H., The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales). J. Antibiot. 36:12 (1983), 1651–1658.
12. Irschik, H., Jansen, R., Höfle, G., Gerth, K., Reichenbach, H., The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria. J. Antibiot. 38:2 (1985), 145–152.
13. Kaiser, D., Social gliding is correlated with the presence of pili in Myxococcus xanthus. Proc. Natl. Acad. Sci. USA 76 (1979), 5952–5956.
14. Kashefi, K., Hartzell, P.L., Genetic suppression and phenotypic masking of a Myxococcus xanthus frzF- defect. Mol. Microbiol. 15:3 (1995), 483–494.
15. Krug, D., Zurek, G., Revermann, O., Vos, M., Velicer, G.J., Müller, R., Discovering the hidden secondary metabolome of Myxococcus xanthus: a study of intraspecific diversity. Appl. Environ. Microbiol. 74:10 (2008), 3058–3068, 10.1128/AEM.02863-07.
16. Lau, J., Frykman, S., Regentin, R., Ou, S., Tsuruta, H., Licari, P., Optimizing the heterologous production of epothilone D in Myxococcus xanthus. Biotechnol. Bioeng. 78:3 (2002), 280–288.
17. Ma, C., Yang, X., Lewis, P.J., Bacterial transcription as a target for antibacterial drug development. Microbiol. Mol. Biol. Rev. 80:1 (2016), 139–160, 10.1128/MMBR.00055-15.
18. Meiser, P., Müller, R., Two functionally redundant Sfp-type 4′-phosphopantetheinyl transferases differentially activate biosynthetic pathways in Myxococcus xanthus. ChemBioChem 9:10 (2008), 1549–1553, 10.1002/cbic.200800077.
19. Moy, T.I., Daniel, A., Hardy, C., Jackson, A., Rehrauer, O., Hwang, Y.S., Zou, D., Nguyen, K., Silverman, J.A., Li, Q., Murphy, C., Evaluating the activity of the RNA polymerase inhibitor myxopyronin B against Staphylococcus aureus. FEMS Microbiol. Lett. 319:2 (2011), 176–179, 10.1111/j.1574-6968.2011.02282.x.
20. Mukhopadhyay, J., Das, K., Ismail, S., Koppstein, D., Jang, M., Hudson, B., Sarafianos, S., Tuske, S., Patel, J., Jansen, R., Irschik, H., Arnold, E., Ebright, R.H., The RNA polymerase “switch region” is a target of inhibitors. Cell 135 (2008), 295–307, 10.1016/j.cell.2008.09.033.
21. Rentsch, A., Kalesse, M., The total synthesis of corallopyronin A and myxopyronin B. Angew. Chem. Int. Ed. Engl. 51:45 (2012), 11381–11384, 10.1002/anie.201206560.
22. Sahner, J.H., Sucipto, H., Wenzel, S.C., Groh, M., Hartmann, R.W., Müller, R., Advanced mutasynthesis studies on the natural α-pyrone antibiotic myxopyronin from Myxococcus fulvus. ChemBioChem 16 (2015), 946–953, 10.1002/cbic.201402666.
23. Sambrook, J., Russell, D.W., Molecular Cloning: A Laboratory Manual. 2001, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
24. Schäberle, T.F., Lohr, F., Schmitz, A., König, G.M., Antibiotics from myxobacteria. Nat. Prod. Rep., 2014, 10.1039/c4np00011k (epub ahead of print).
25. Schäberle, T.F., Mohseni, M.M., Lohr, F., Schmitz, A., König, G.M., Function of the loading module in CorI and of the O-methyltransferase CorH in vinyl carbamate biosynthesis of the antibiotic corallopyronin A. Antimicrob. Agents Chemother. 58:2 (2014), 950–956, 10.1128/AAC.01894-13.
26. Schäberle, T.F., Schiefer, A., Schmitz, A., König, G.M., Hoerauf, A., Pfarr, K., Corallopyronin A – a promising antibiotic for treatment of filariasis. Int. J. Med. Microbiol. 304:1 (2014), 72–78, 10.1016/j.ijmm.2013.08.010.
27. Schäberle, T.F., Schmitz, A., Zocher, G., Schiefer, A., Kehraus, S., Neu, E., Roth, M., Vassylyev, D.G., Stehle, T., Bierbaum, G., Hoerauf, A., Pfarr, K., König, G.M., Insights into structure-activity relationships of bacterial RNA polymerase inhibiting corallopyronin derivatives. J. Nat. Prod. 78:10 (2015), 2505–2509, 10.1021/acs.jnatprod.5b00175.
28. Schiefer, A., Schmitz, A., Schäberle, T.F., Specht, S., Lämmer, C., Johnston, K.L., Vassylyev, D.G., König, G.M., Hoerauf, A., Pfarr, K., Corallopyronin A specifically targets and depletes essential obligate wolbachia endobacteria from filarial nematodes in vivo. J. Infect. Dis. 206:2 (2012), 249–257, 10.1093/infdis/jis341.
29. Srivastava, A., Talaue, M., Liu, S., Degen, D., Ebright, R.Y., Sineva, E., Chakraborty, A., Druzhinin, S.Y., Chatterjee, S., Mukhopadhyay, J., Ebright, Y.W., Zozula, A., Shen, J., Senqupta, S., Niedfeldt, R.R., Xin, C., Kaneko, T., Irschik, H., Jansen, R., Donadio, S., Connell, N., Ebright, R.H., New target for inhibition of bacterial RNA polymerase: ‘switch region’. Curr. Opin. Microbiol. 14:5 (2011), 532–543, 10.1016/j.mib.2011.07.030.
30. Srivastava, A., Degen, D., Ebright, Y.W., Ebright, R.H., Frequency, spectrum, and nonzero fitness costs of resistance to myxopyronin in Staphylococcus aureus. Antimicrob. Agents Chemother. 56:12 (2012), 6250–6255, 10.1128/AAC.01060-12.
31. Sucipto, H., Wenzel, S.C., Müller, R., Exploring chemical diversity of a-pyrone antibiotics: molecular basis of myxopyronin biosynthesis. ChemBioChem 14:13 (2013), 1581–1589, 10.1002/cbic.201300289.
32. Sucipto, H., Sahner, J.H., Prusov, E., Wenzel, S.C., Hartmann, R., Koehnke, J., Müller, R., In Vitro reconstitution of α-Pyrone ring formation in myxopyronin biosynthesis. Chem. Sci. 6 (2015), 5076–5085, 10.1039/C5SC01013F.
33. Weissman, K.J., Müller, R., Myxobacterial secondary metabolites: bioactivities and modes-of-action. Nat. Prod. Rep. 27:9 (2010), 1276–1295, 10.1039/c001260m.
34. Wenzel, S.C., Müller, R., Host organisms: myxobacterium. Wittmann, Liao, (eds.) Industrial Biotechnology, 2017, 453–485.
35. Zhang, Y., Buchholz, F., Muyrers, J.P., Stewart, F.A., A new logic for DNA engineering using recombination in Escherichia coli. Nat. Genet. 20 (1998), 123–128.
36. Zocher, G., Vilstrup, J., Heine, D., Hallab, A., Goralski, E., Hertweck, C., Stahl, M., Schäberle, T.F., Stehle, T., Structural basis of head to head polyketide fusion by CorB. Chem. Sci. 6:11 (2015), 6525–6536, 10.1039/C5SC02488A.